Auteur/autrice : oxeltis

IS3NA – IRT 2021, August 26-27

Le 20 août 2021 par oxeltis

Oxeltis is happy to participate and sponsor IS3NA-IRT 2021 Virtual meeting. Looking forward contacting you about your nucleos(t)ides medchem and custom synthesis programs. https://www.is3na.org/events-1/2021-virtual-symposium

GECO 2021 – 25 au 27 août 2021

Le 20 août 2021 par oxeltis

Oxeltis est heureux de participer et de sponsoriser le GECO 2021. Retrouvez-nous pour tous besoins de ressources externes sur vos programmes de chimie médicinale et de synthèse à façon. https://geco61.sciencesconf.org/

RICT 2021 — Jul 7-9, 2021

Le 2 juillet 2021 par oxeltis

Oxeltis' scientists are participating to RICT 2021, lets connect and interact ! Why not planning a virtual meeting at contact@oxeltis.com https://www.rict2021.org/

HAVE A DIGITAL MEETING WITH OXELTIS AT RESI: JUNE 8-10, 2021

Le 17 mai 2021 par oxeltis

https://resiconference.com Connect with Oxeltis at Resi Conference, 8-10 June 2021 #medicinalchemistry #smallmolecules #antivirals #medchemservices #networkinghttps://resiconference.com

Oxeltis appoints director of chemistry and consultant in medicinal chemistry to deliver new development strategy

Le 9 novembre 2020 par oxeltis

Dr Stéphane Salamone and Dr Olivier Lavergne will be instrumental in boosting additional lab and medchem capabilities at the company Montpellier, France, November 9, 2020 – Oxeltis, a medicinal chemistry (...)

Sars-Cov 2 and business continuity at Oxeltis

Le 21 avril 202022 avril 2020 par oxeltis

At Oxeltis, we are committed to continuing our medicinal chemistry research services during the Sars-Cov 2 outbreak, with respect to our staff’s safety and in accordance with the rules put in (...)

Tokyo (Japan) – medicinal chemistry symposium, nov 27-29, 2019

Le 13 novembre 2019 par oxeltis

For the second year, Oxeltis is participating to the Medicinal Chemistry Symposium organized by the Pharmaceutical Society of Japan. Please visit us at Oxeltis booth #9 to talk about your (...)

R&D tax credit, 2020-2024 accreditation

Le 12 novembre 2019 par oxeltis

Oxeltis is pleased to announce to its customers and R&D partners the renewal of its agreement for R&D tax credit (agrément Crédit Impôt Recherche) by the French Ministry of Higher (...)

20th SCI/RSC Medicinal Chemistry Symposium

Le 4 septembre 20194 septembre 2019 par oxeltis

Meet Oxeltis in Cambridge (UK), Sept 8-11, 2019, at the 20th SCI / RSC Medicinal Chemistry Symposium, Europe’s premier biennial Medicinal Chemistry event, focussing on first disclosures and new strategies (...)

Chem outsourcing – New Jersey-USA (Sept 17-19, 2019)

Le 30 août 201930 août 2019 par oxeltis

Meet Oxeltis for Medicinal chemistry FTE services and FFS custom synthesis at ChemOutsourcing in Parsippany (NJ) very soon... ChemOutsourcing is the largest USA-based API and Pharmaceutical Ingredients Sept show attracting (...)